Home > National Drug Code (NDC) > Carbidopa, Levodopa and Entacapone

Carbidopa, Levodopa and Entacapone - 47335-909-18 - (Carbidopa, Levodopa and Entacapone)

Alphabetical Index


Drug Information of Carbidopa, Levodopa and Entacapone

Product NDC: 47335-909
Proprietary Name: Carbidopa, Levodopa and Entacapone
Non Proprietary Name: Carbidopa, Levodopa and Entacapone
Active Ingredient(s): 25; 200; 100    mg/1; mg/1; mg/1 & nbsp;   Carbidopa, Levodopa and Entacapone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa, Levodopa and Entacapone

Product NDC: 47335-909
Labeler Name: Sun Pharma Global FZE
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA079085
Marketing Category: ANDA
Start Marketing Date: 20120522

Package Information of Carbidopa, Levodopa and Entacapone

Package NDC: 47335-909-18
Package Description: 1000 TABLET, FILM COATED in 1 BOTTLE (47335-909-18)

NDC Information of Carbidopa, Levodopa and Entacapone

NDC Code 47335-909-18
Proprietary Name Carbidopa, Levodopa and Entacapone
Package Description 1000 TABLET, FILM COATED in 1 BOTTLE (47335-909-18)
Product NDC 47335-909
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa, Levodopa and Entacapone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120522
Marketing Category Name ANDA
Labeler Name Sun Pharma Global FZE
Substance Name CARBIDOPA; ENTACAPONE; LEVODOPA
Strength Number 25; 200; 100
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC]

Complete Information of Carbidopa, Levodopa and Entacapone


General Information